ASD Centers, LLC
Where Medical Solutions for Autism Can Be Found...

Research




The ASD Centers, LLC is committed to undertaking cutting-edge research to help to identify the etiological basis and treatment of autism spectrum disorders.

ASD Centers, LLC staff have received financial support for their research from such prestigous autism and research funding organizations as the Autism Research Institute (ARI), the Brenen Hornstein Autism Research and Education (BHARE) Foundation, the Yates Foundation for Autism, the International Academy of Oral Medicine & Toxicology, the Institute of Chronic Illnesses, Inc., and CoMeD, Inc. Further, ASD Centers, LLC staff have conducted cutting-edge research at such prestigious institutions as the National Institutes of Health and the Johns Hopkins University. The following are peer-reviewed scientific/medical studies and other important publications:


Kern JK, Geier DA, Audhya T, King PG, Sykes LK, Geier MR. Evidence of parallels between mercury intoxication and the brain pathology in autism. Acta Neurobiol Exp 2012;72:113-53. [Full Text Click Here]



Geier DA, Pretorius HT, Richards NM, Geier MR. A quantitative evaluation of brain dysfunction and body-burden of toxic metals. Med Sci Monit 2012;18:CR425-431. [Full Text Click Here]

 


Geier DA, Kern JK, King PG, Sykes LK, Geier MR. An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders. Acta Neurobiol Exp 2012;72:1-17.
[Full Text Click Here]



Geier DA, King PG, Sykes LK, Geier MR. The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS). Med Sci Monit 2012;18:PH12-17. [Full Text Click Here]



Geier DA, Carmody T, Kern JK, King PG, Geier MR. A dose-dependent relationship between mercury exposure from dental amalgams and urinary mercury levels: a further assessment of the Casa Pia Children's Dental Amalgam Trial. Hum Exp Toxicol 2012;31:11-17. [Full Text Click Here]



Kern JK, Geier DA, Adams JB, Garver CR, Audhya T, Geier MR. A clinical trial of glutathione supplmenentation in autism spectrum disorders. Med Sci Monit 2011;17:CR677-82. [Full Text Click Here]



Kern JK, Geier DA, Adams JB, Mehta JA, Grannemann BD, Geier MR. Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins. Pediatr Int 2011;53:147-53.  [Full Text Click Here]



Geier DA, Kern JK, Davis G, King PG, Adams JB, Young JL, Geier MR. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Med Sci Monit 2011;17:PI15-23. [Full Text Click Here]



Geier DA, Sykes LK, Geier MR. The role and treatment of elevated male homrones in autism spectrum disorders. Autism Science Digest 2011;1:70-5. [Full Text Click Here]



Kern JK, Geier DA, Adams JB, Troutman MR, Davis G, King PG, Young JL, Geier MR. Autism severity and muscle strength: a correlation analysis. Res Autism Spectr Disord 2011;5:1011-15. [Full Text Click Here]



Geier DA, Carmody T, Kern JK, King PG, Geier MR. A significant relationship between mercury exposure from dental amalgams and urinary porphyrins: a further assessment of the Casa Pia children's dental amalgam trial. Biometals 2011;24:215-24. [Full Text Click Here]



Kern JK, Geier DA, Ayzac F, Adams JB, Mehta JA, Geier MR. Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins. Toxicol Environ Chem 2011;93:396-405. [Full Text Click Here]



Kern JK, Geier DA, Adams JB, Geier MR. A biomarker of mercury burden-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder. Biometals 2010;23:1043-51. [Full Text Click Here]



Geier DA, Kern JK, Geier MR. The biological basis of autism spectrum disorders: Understanding causation and treatment by clinical geneticsts. Acta Neurobiol Exp (Wars) 2010;70:209-26. [Full Text Click Here]



Geier DA, Audhya T, Kern JK, Geier MR. Blood mercury levels in autism spectrum disorder: Is there a threshold level? Acta Neurobiol Exp (Wars) 2010;70:177-86. [Full Text Click Here]



Geier DA, Jordan SK, Geier MR. The relative toxicity of compounds used as preservatives in vaccines and biologics. Med Sci Monit 2010;16(5):SR21-7. [Full Text Click Here]



Geier DA, Geier MR. An autism cohort study of cobalt levels following vitamin B12 injections. Toxicol Environ Chem 2010;92:1025-37. [Full Text Click Here]



Geier DA, Young HA, Geier MR. Thimerosal exposure & increasing trends of premature puberty in the Vaccine Safety Datalink. Indian J Med Res 2010;131:500-7. [Full Text Click Here]



Geier DA, Kern JK, Geier MR. A prospective blinded evaluation of urinary porphyrins vs the clinical serverity of autism spectrum disorders. J Toxicol Environ Health A 2009;72:1585-91.  [Full Text Click Here]



Geier MR, Geier DA, Sykes LK. Important insights regarding new testing and treatment for autism spectrum disorders. The Autism File USA 2009;32:88-91.  [Full Text Click Here]



Geier DA, Kern JK, Geier MR. A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity. Acta Neurobiol Exp (Wars) 2009;69:189-97. [Full Text Click Here]



Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR. Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci 2009;280:101-8. [Full Text Click Here]



Geier MR, Geier DA, Sykes LK. The shifting role of genes in the autism epidemic. The Autism File USA 2009;31:26-9. [Full Text Click Here]



Geier DA, King PG, Geier MR. Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and cell death in human neuronal and fetal cells induced by low-level exposure to Thimerosal and other metal compounds. Toxicol Environ Chem 2009;91:735-49. [Full Text Click Here]



Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR. A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 2009;34:386-93. [Full Text Click Here]



Geier DA,Kern JK, Geier MR. A prospective study of oxidative stress biomarkers in autistic disorders. Electronic Journal of Applied Psychology 2009;5:2-10. [Full Text Click Here]



Geier DA, King PG, Sykes LK, Geier MR. A comprehensive review of mercury provoked autism. Indian J Med Res 2008;128:383-411. [Full Text Click Here]



Geier DA, Geier MR. Autism spectrum disorder-associated biomarkers for case evaluation and management by clinical geneticists. Expert Rev Mol Diagn 2008;8:671-4. [Full Text Click Here]



Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 2008;271:110-8. [Full Text Click Here]



Geier DA, Mumper E, Gladfelter B, Coleman L, Geier MR. Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment. Neuro Endocrinol Lett 2008;29:272-80. [Full Text Click Here]



Geier DA, Sykes LK, Geier. A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J Toxicol Environ Health B Crit Rev 2007;10:575-96. [Full Text Click Here]



Geier DA, Geier MR. A prospective assessment of androgen levels in patients diagnosed with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett 2007;28:565-73. [Full Text Click Here]



Geier DA, Geier MR. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health A 2007;70:1723-30. [Full Text Click Here]



Geier DA, Geier MR. A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders. J Matern Fetal Neonatal Med 2007;20:385-90. [Full Text Click Here]



Geier DA, Geier MR. A case-series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. J Toxicol Environ Health A 2007;70:837-51. [Full Text Click Here]



Geier DA, Geier MR. A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. Neuro Endocrinol Lett 2006;27:833-8. [Full Text Click Here]



Geier DA, Geier MR. A prospective assessment of porphyrins in autisitic disorders: a potential marker for heavy metal exposure. Neurotox Res 2006;10:57-64. [Full Text Click Here]



Geier DA, Geier MR. Early downward trends in neurodevelopmental disorders following removal of Thimerosal-containing vaccines. J Am Phys Surg 2006;11:8-13.  [Full Text Click Here]



Geier DA, Geier MR. A clinical and laboratory evaluation of methionine cycle-transsulfuration and adrogen pathway markers in children with autistic disorders. Horm Res 2006;66:182-8. [Full Text Click Here]



Geier DA, Geier MR. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett 2006;27:401-13. [Full Text Click Here]



Geier DA, Geier MR. An evaluation of the effects of Thimerosal on neurodevelopmental disorders following DTP and Hib vaccines in comparison to DTPH vaccine in the United States. J Toxicol Environ Health A 2006;69:1481-95. [Full Text Click Here]



Geier DA, Geier MR. An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines. Med Sci Monit 2006;12:CR231-9. [Full Text Click Here]



Geier DA, King PG, Geier MR. Influenza vaccine: review of effectiveness of the U.S. immunization program, and policy considerations. J Am Phys Surg 2006;11:69-74. [Full Text Click Here]



Geier MR, Geier DA. The potential importance of steriods in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med Hypotheses 2005;64:946-54. [Full Text Click Here]



Geier DA, Geier MR. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. Med Sci Monit 2005;11:CR160-70. [Full Text Click Here]



Geier DA, Geier MR. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Brain Dev 2004;26:296-300. [Full Text Click Here]



Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identicical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol 2004;22:749-55.
 [Full Text Click Here]


Geier DA, Geier MR. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis. Int J Toxicol 2004;23:369-76. [Full Text Click Here]



Geier DA, Geier MR. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit 2004;10:PI33-9. [Full Text Click Here]



Bradstreet J, Geier DA, Kartzinel JJ, Adams JB, Geier MR. A case-control study of mercury burden in children with autistic spectrum disorders. J Am Phys Surg 2003;8:76-9. [Full Text Click Here]



Geier DA, Geier MR. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatr Rehabil 2003;6:97-102. [Full Text Click Here]



Geier MR, Geier DA. Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States. J Am Phy Surg 2003;8:6-11. [Full Text Click Here]



Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med (Maywood) 2003;228:660-4. [Full Text Click Here]



Geier D, Geier M. The true story of pertussis vaccination: a sordid legacy? J Hist Med Allied Sci 2002;57:249-84. [Full Text Click Here]



Geier DA, Geier MR. Clinical implications of endotoxin concentrations in vaccines. Ann Pharmacother 2002;36:776-80. [Full Text Click Here]



Geier MR, Geier DA. The state of polio vaccination in the world: the case for continuing routine vaccination. Toxicol Mech Methods 2002;12:221-8. [Full Text Click Here]



Geier DA, Geier MR. Rubella vaccine and arthritic adverse reactions: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1998. Clin Exp Rheumatol 2001;19:724-6. [Full Text Click Here]



Geier MR, Geier DA. Arthritic reactions following hepatitis B vaccination: analysis of the vaccine adverse events reporting sytem (VAERS) data from 1990 through 1997. Clin Exp Rheumatol 2000;18:789-90. [Full Text Click Here]




Geier MR, Stanbro H, Merril CR. Endotoxins in commercial vaccines. Appl Environ Microbiol 1978;36:445-9. [Full Text Click Here]



LaPolla RJ, Geier MR. Friedman TB, Merril CR. CO2 porduction from galactose in galactose-1-phosphate uridyl transferase-deficient Escherichia coli. J Bacteriol 1975;124:558-61. [Full Text Click Here]



Trigg ME, Geier MR, LaPolla RJ, Kamerow HN, Merril CR. Addition of leucine precursors to the diet of leucine-starved mice. Am J Clin Nutr 1975;28:947-9. [Full Text Click Here]



Geier MR, Attallah AF, Merril CR. Characterization of Escherichia coli bacterial viruses in commerical sera. In Vitro 1975;11:55-8. [Full Tex Click Here]



Geier MR, Trigg ME, Merril CR. Fate of bacteriophage lambda in non-immune germ-free mice. Nature 1973;246:221-3. [Full Text Click Here]



Merril CR, Friedman TB, Attallah AF, Geier MR, Krell K, Yarkin R. Isolation of bacteriophages from commercial sera. In Vitro 1972;8:91-3. [Full Text Click Here]



Merril CR, Geier MR, Petricciani JC. Bacterial virus gene expressioin in human cells. Nature 1971;233:398-400. [Full Text Click Here]

    






                                             

Call for an appointment today





ASD Centers is proud to announce that you can now follow the latest developments regarding our company on:


Facebook                           Twitter


                        


ASD Centers Corporate Office
14 Redgate Ct
Silver Spring, MD 20905
Phone: (301)989-0548
Fax: (301)989-1543
email: asdadmin@comcast.net

 

Web Hosting